InsidersTradesSigma
Follow the Sunshine Biopharma Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 11 August 2026 (Attribution). Among the most active insiders: NATAN DAVID. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Sunshine Biopharma Inc. is a company focused on developing drugs for cancer treatment. It is listed on NASDAQ under the ticker SBFM.